Aethlon Medical (AEMD) Shares Outstanding (Diluted Average) (2021 - 2025)
Aethlon Medical filings provide 6 years of Shares Outstanding (Diluted Average) readings, the most recent being $1.6 million for Q1 2025.
- On a quarterly basis, Shares Outstanding (Diluted Average) rose 396.93% to $1.6 million in Q1 2025 year-over-year; TTM through Mar 2025 was $1.6 million, a 396.93% increase, with the full-year FY2025 number at $1.6 million, up 396.93% from a year prior.
- Shares Outstanding (Diluted Average) hit $1.6 million in Q1 2025 for Aethlon Medical, up from $147520.0 in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $15.5 million in Q2 2022 to a low of $133944.0 in Q3 2024.
- Median Shares Outstanding (Diluted Average) over the past 5 years was $2.2 million (2023), compared with a mean of $5.6 million.
- Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 94.61% in 2024 and later skyrocketed 396.93% in 2025.
- Aethlon Medical's Shares Outstanding (Diluted Average) stood at $14.5 million in 2021, then tumbled by 86.43% to $2.0 million in 2022, then rose by 25.49% to $2.5 million in 2023, then tumbled by 94.05% to $147520.0 in 2024, then skyrocketed by 958.05% to $1.6 million in 2025.
- The last three reported values for Shares Outstanding (Diluted Average) were $1.6 million (Q1 2025), $147520.0 (Q4 2024), and $133944.0 (Q3 2024) per Business Quant data.